A股異動|北汽藍谷升超9% 本奧米爾集團確定採購600輛極狐作為首批訂單
北汽藍谷(600733.SH)升超9%,報6.12元,總市值341.1億元。北汽藍谷12日在互動平台表示,10月9日北汽藍谷極狐汽車科技有限公司與阿聯酋本奧米爾控股集團有限公司簽署合作協議。雙方計劃聯手開拓阿聯酋和沙特兩大中東市場,極狐品牌汽車將成為此次出海的主力產品。目前,本奧米爾集團已確定採購600輛極狐作為首批訂單。此外,北汽藍谷稱,公司本年度銷量增勢明顯,上半年同比銷量增長106.88%。同時,極狐還在持續完善產品矩陣,全面突破15萬到30萬的純電市場。今明兩年,極狐將以場景造車為理念,陸續推出多款新品,實現產品策略從競品對標到場景化應用的轉型。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.